DK0552269T3 - Blodpladeadhæsionsinhibitor - Google Patents

Blodpladeadhæsionsinhibitor

Info

Publication number
DK0552269T3
DK0552269T3 DK91919350.8T DK91919350T DK0552269T3 DK 0552269 T3 DK0552269 T3 DK 0552269T3 DK 91919350 T DK91919350 T DK 91919350T DK 0552269 T3 DK0552269 T3 DK 0552269T3
Authority
DK
Denmark
Prior art keywords
pct
date apr
sec
leech
platelet adhesion
Prior art date
Application number
DK91919350.8T
Other languages
English (en)
Inventor
Roy T Sawyer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0552269T3 publication Critical patent/DK0552269T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DK91919350.8T 1990-10-10 1991-10-10 Blodpladeadhæsionsinhibitor DK0552269T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909022040A GB9022040D0 (en) 1990-10-10 1990-10-10 Platelet adhesion inhibitor
PCT/GB1991/001763 WO1992007005A1 (en) 1990-10-10 1991-10-10 Platelet adhesion inhibitor

Publications (1)

Publication Number Publication Date
DK0552269T3 true DK0552269T3 (da) 1997-11-03

Family

ID=10683506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919350.8T DK0552269T3 (da) 1990-10-10 1991-10-10 Blodpladeadhæsionsinhibitor

Country Status (12)

Country Link
US (1) US5587360A (da)
EP (1) EP0552269B1 (da)
JP (1) JP3558292B2 (da)
AT (1) ATE154034T1 (da)
AU (1) AU659807B2 (da)
CA (1) CA2093819C (da)
DE (1) DE69126437T2 (da)
DK (1) DK0552269T3 (da)
ES (1) ES2103831T3 (da)
GB (1) GB9022040D0 (da)
GR (1) GR3024437T3 (da)
WO (1) WO1992007005A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT662088E (pt) * 1993-07-01 2002-06-28 Merck Patent Gmbh Inibidor da agregacao de plaquetas estimulada por colagenio
ES2153760B1 (es) * 1998-11-25 2001-07-01 Univ Barcelona Autonoma Inhibidor de metalocarboxipeptidasas como agente fibrinolitico.
EP1161530B1 (en) * 1999-03-18 2005-05-18 MERCK PATENT GmbH Protein for blocking platelet adhesion
MY128992A (en) * 2000-08-25 2007-03-30 Merck Patent Gmbh Saratin for inhibiting platelet adhesion to collagen
US20110034396A1 (en) * 2005-09-28 2011-02-10 Biovascular, Inc. Methods and compositions for inhibiting cell migration and treatment of inflammatory conditions
US7691839B2 (en) 2005-09-28 2010-04-06 Biovascular, Inc. Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation
EP2316465A1 (en) * 2009-10-15 2011-05-04 Centre National De La Recherche Scientifique Use of extract of leeches' saliva as anti-bacterial agent for the manufacture of different compositons
ES2610556T3 (es) 2011-01-31 2017-04-28 Council Of Scientific & Industrial Research 1-(4-metilfenilmetil)-5-oxo-{N-[(3-t-butoxicarbonil-aminometil)]-piperidin-1-il}-pirrolidin-2-carboxamidas quirales como inhibidores de la activación y adhesión de plaquetas inducidas por colágeno
CN107287269A (zh) * 2017-06-19 2017-10-24 山东大学 一种减轻水蛭出血不良反应的水蛭肽制备工艺
EP3870598A1 (en) 2018-10-23 2021-09-01 Dragonfly Therapeutics, Inc. Heterodimeric fc-fused proteins
IL297495A (en) 2020-04-22 2022-12-01 Dragonfly Therapeutics Inc Dosing regimen, formulation and manufacturing process for fc fusion heterodimeric proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
US4588587A (en) * 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
US5139944A (en) * 1985-08-10 1992-08-18 Biophram (Uk) Limited Collagen-specific enzyme with platelet aggregation inhibition properties
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US4832849A (en) * 1988-06-16 1989-05-23 Merrell Dow Pharmaceuticals Inc. Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
IL86857A (en) * 1988-06-24 1994-04-12 Yissum Res Dev Co Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same

Also Published As

Publication number Publication date
DE69126437D1 (de) 1997-07-10
CA2093819C (en) 2002-04-30
EP0552269B1 (en) 1997-06-04
JP3558292B2 (ja) 2004-08-25
ES2103831T3 (es) 1997-10-01
DE69126437T2 (de) 1997-12-04
GB9022040D0 (en) 1990-11-21
AU659807B2 (en) 1995-06-01
JPH06505703A (ja) 1994-06-30
ATE154034T1 (de) 1997-06-15
CA2093819A1 (en) 1992-04-11
AU8666691A (en) 1992-05-20
WO1992007005A1 (en) 1992-04-30
US5587360A (en) 1996-12-24
EP0552269A1 (en) 1993-07-28
GR3024437T3 (en) 1997-11-28

Similar Documents

Publication Publication Date Title
DK0552269T3 (da) Blodpladeadhæsionsinhibitor
FR2678624B1 (da)
DE69433356D1 (de) An der oberfläche modifizierte, biocompatible membranen
DE59308220D1 (de) Schwungphasensteuervorrichtung
NZ331758A (en) Isolated dimeric fibroblast activation protein alpha and a method of cleaving a terminal dipeptide
KR950702966A (ko) 성장 호르몬의 방출을 촉진시키는 벤조 융합된 락탐(Benzo-fused lactams promote release of growth hormone)
SE9103701D0 (sv) Apolipoprotein
NO944997L (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ES2114616T5 (es) Acidos dicarboxilicos alifaticos insaturados.
EE03331B1 (et) Vahend tapetud loomakehade säilivuse suurendamiseks
ATE198624T1 (de) Expression von albumin in hefe
DE69329031D1 (de) Das dorsalgewebe beeinflussender faktor
UA41332C2 (uk) Білок, здатний інгібувати стимульовану колагеном агрегацію тромбоцитів, спосіб його одержання, фармацевтичний препарат, спосіб обробки імплантованого або екстракорпорального медичного пристрою та спосіб одержання лікарського засобу
GB9411009D0 (en) Dialysis fluid
ATE190839T1 (de) Verwendung von prodelphidinen zur behandlung von arthrose
ATE227557T1 (de) Verwendung von zahnpflegemitteln enthaltend bovines kolostrum
BR9407669A (pt) Bandagem de ferida que compreende alginato
AU4757393A (en) Modified platelet factor-4
ES2097931T3 (es) Nueva proteina inhibidora de trombina a partir de chinches cazadoras.
Sawyer Platelet adhesion inhibitor
ATE231001T1 (de) Verwendung von protein c inhibitor zur behandlung disseminierter intravasaler gerinnung (dic)
DK0609242T3 (da) Nyt thrombininhibitorisk protein fra blodmider
ATE58460T1 (de) Nahrungsmittel auf der basis von schaffleisch.
NO961995L (no) Anvendelse av IGF-BP for renaturering av IGF